TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
TerminatedN/A

Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease

This is a study to evaluate Deep brain stimulation (DBS) burst-type electrical stimulation programming verses standard DBS programming. Burst-type DBS is defined as a novel stimulation protocol in which intermittent bursts of traditional hi

Pittsburgh, Pennsylvania, United StatesView details
CompletedN/A

Aerobic Exercise and Brain Health in Parkinson's

The purpose of the project is to investigate how moderate to high intensity aerobic exercise affects brain health in patients with Parkinson's disease. Assessments include MRI, blood markers, cognition, functional tests, questionnaires, and

Aarhus, Aarhus C, DenmarkView details
UnknownN/A

Efficacy of Nano-PSO in Parkinson's Disease.

The present research aims to carry out a double-blind, placebo-controlled clinical trial to study the efficacy of a new antioxidant. The primary outcome variables will be the changes observed in PD-motor and non-motor symptoms scales, as we

Mexico City, Mexico City, MexicoView details
RecruitingN/A

Serum Biomarkers in Parkinson's Disease at Different Stages

* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease.

Roma, ItalyView details
RecruitingN/A

Impact of a Biophoton Therapy on Patients With Brain Disorders

Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is

Butler, Pennsylvania, United StatesView details
CompletedN/A

Effect of Noninvasive Brain Stimulation on Hypokinetic Dysarthria in Parkinson's Disease

Hypokinetic dysarthria (HD) is common in Parkinson's disease (PD) patients and responds only partially to pharmacotherapy and surgery. The investigators will explore long-term effects of repetitive transcranial magnetic stimulation (rTMS) a

Brno, CzechiaView details
CompletedN/A

Treadmill in the Rehabilitation of Parkinsonian Gait

Gait disorders represent disabling symptoms in Parkinson's Disease (PD). The effectiveness of rehabilitation treatment with Body Weight Support Treadmill Training (BWSTT) has been demonstrated in patients with stroke and spinal cord injurie

Multiple locationsView details
CompletedPhase 3

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

This is a study to compare the efficacy of IPX066 and CLE in subjects with advanced Parkinson's disease.

Fresno, California, United States+23 moreView details
CompletedPhase 2

A Phase 2A Trial of EPI-743 for Patients With Parkinson's Disease

The purpose of this study is to evaluate the effects of EPI-743 in patients with Parkinson's disease.

Tampa, Florida, United StatesView details
UnknownN/A

Exercise Targeting Cognitive Impairment in Parkinson's Disease

The aim of this application is to compare and elucidate the effects of skill-based versus aerobic exercise versus control on mild cognitive impairment (MCI) of the executive function (EF) subtype in Parkinson's disease (PD); we hypothesize

Los Angeles, California, United StatesView details
RecruitingN/A

Temporal Interference Stimulation on Motor Symptoms in Parkinson's Disease

The goal of this clinical trial is to learn whether a type of brain stimulation called transcranial temporal interference stimulation (TIS) of the internal globus pallidus (GPi) can help improve movement symptoms in people with Parkinson's

Shanghai, Shanghai Municipality, ChinaView details
UnknownEARLY_Phase 1

SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis

Parkinson's disease is often characterised by movement symptoms such as rigidity and bradykinesia, however, there are a number of non-motor symptoms that can have a significant impact on quality of life. One of the most common non-motor sym

London, Camberwell, United KingdomView details
CompletedN/A

Effects of Different Percentages Body Weight Supported Treadmill Training on Gait, Balance, Quality of Life and Fatigue in Parkinson's Disease

Body weight supported treadmill training (BWSTT) is an important rehabilitative choice for neurologically impaired subjects such as Parkinson's disease (PD). The aim of the study is to evaluate the effectiveness of different percentages BWS

Çorum, Turkey (Türkiye)View details
CompletedN/A

Improving Dexterous Skills in Parkinson's Disease

Background and aim: Patients with Parkinson's disease (PD) exhibit disturbed manual dexterity. This impairment leads to difficulties in activities of daily living (ADL) such as buttoning a T-shirt or hand-writing.

Lucerne, Canton of Lucerne, SwitzerlandView details
CompletedN/A

Analgesic Effects of Expectation and Deep Brain Stimulation in Patients With Parkinson's Disease

The study investigates analgesic effects of expectations and deep brain stimulation on chronic and evoked pain in patients with Parkinson's disease. The study includes patients with Parkinson's disease that are exposed to pain stimuli throu

Aarhus, DenmarkView details
Unknown

Automatic Recognition of Freezing of Gait Episodes

The investigators hypothesize that mathematical algorithm can identify freezing episodes based on data obtained from accelerometer.

Tel Aviv, IsraelView details
RecruitingPhase 2

Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)

This Phase 2a, multicenter, randomized, 12-week double-blind, placebo-controlled, parallel-group study, followed by an OLE, is designed to evaluate the safety, tolerability, and pharmacodynamic effects of BIIB122 in participants with LRRK2-

Los Angeles, California, United States+19 moreView details
CompletedPhase 1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease

The purpose of the study is to assess the safety, tolerability, and pharmacokinetics of single, ascending doses of ABBV-951 administered as a subcutaneous bolus infusion followed by a continuous subcutaneous infusion in subjects with Parkin

Glendale, California, United States+6 moreView details
By invitation

Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System

Description of a method to detect Parkinson's disease or Parkinson's-like disease at an early stage (Prodromal Parkinson's Disease) where damage is still confined to the peripheral nervous system damage. Simultaneous collection of biologica

Aarhus, Jutland, DenmarkView details
CompletedPhase 4

Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors

The purpose of this study is to determine whether oral intake of COMT inhibitors affects the smooth plasma levodopa levels achieved by intestinal levodopa/carbidopa infusion in advanced Parkinson's disease patients. The hypothesis is that C

Uppsala, SwedenView details
Load more trials